Group 1 - The company has announced the cancellation of a special account for raised funds, transferring the remaining balance of RMB 3,962.27 to its general account for daily operational liquidity [4][6] - The total amount raised from the initial public offering (IPO) was RMB 186,463.34 million, with a net amount of RMB 159,551.73 million after deducting issuance costs [2][3] - The company had established a special account for the management and storage of raised funds, in compliance with regulatory requirements and signed a tripartite supervision agreement with the sponsor and the bank [3][4] Group 2 - The cancellation of the special account was conducted to streamline bank account management and reduce administrative costs [4] - The company has completed the necessary procedures for the cancellation of the special account, which also terminates the related supervision agreement [4][6] - The raised funds were subject to specific management protocols to protect investor interests, as outlined in various regulatory documents [3]
上海优宁维生物科技股份有限公司关于注销募集资金专项账户的公告